NCT05498779View on ClinicalTrials.gov

Ablation of Hepatocellular Carcinoma: a Nationwide Study

CompletedOBSERVATIONAL
Enrollment

490

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
Hepatocellular CarcinomaAblationHepatitis C
Interventions
PROCEDURE

Ablation therapy

Radiofrequency or microwave ablation

Trial Locations (1)

2100

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER